Affiliation:
1. University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, Kuopio, Finland
2. Zewail City of Science and Technology, Giza, Egypt
3. Department of Neuroimaging, Alzheimer’s Disease Research Centre, Reina Sofia-CIEN Foundation, Madrid, Spain
4. Laboratory for Clinical Neuroscience, CTB, Universidad Politécnica de Madrid, Madrid, Spain
Abstract
Background: Quantitatively predicting the progression of Alzheimer’s disease (AD) in an individual on a continuous scale, such as the Alzheimer’s Disease Assessment Scale-cognitive (ADAS-cog) scores, is informative for a personalized approach as opposed to qualitatively classifying the individual into a broad disease category. Objective: To evaluate the hypothesis that the multi-modal data and predictive learning models can be employed for future predicting ADAS-cog scores. Methods: Unimodal and multi-modal regression models were trained on baseline data comprised of demographics, neuroimaging, and cerebrospinal fluid based markers, and genetic factors to predict future ADAS-cog scores for 12, 24, and 36 months. We subjected the prediction models to repeated cross-validation and assessed the resulting mean absolute error (MAE) and cross-validated correlation (ρ) of the model. Results: Prediction models trained on multi-modal data outperformed the models trained on single modal data in predicting future ADAS-cog scores (MAE12, 24 & 36 months= 4.1, 4.5, and 5.0, ρ12, 24 & 36 months= 0.88, 0.82, and 0.75). Including baseline ADAS-cog scores to prediction models improved predictive performance (MAE12, 24 & 36 months= 3.5, 3.7, and 4.6, ρ12, 24 & 36 months= 0.89, 0.87, and 0.80). Conclusion: Future ADAS-cog scores were predicted which could aid clinicians in identifying those at greater risk of decline and apply interventions at an earlier disease stage and inform likely future disease progression in individuals enrolled in AD clinical trials.
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference60 articles.
1. Mitigating Alzheimer’s disease with natural polyphenols: A review;Gaudreault;Curr Alzheimer Res,2019
2. Learning from the past: A review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer’s disease;Ceyzériat;Curr Alzheimer Res,2020
3. 2019 Alzheimer’s disease facts and figures;Alzheimer’s Association;Alzheimers Dement,2019
4. Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI);Mueller;Alzheimers Dement,2005
5. Nie L , Zhang L , Yang Y , Wang M , Hong R , Chua T-S (2015) Beyond doctors. In Proceedings of the 23rd ACM international conference on Multimedia -MM’ 15ACMPress, New York, New York, USA, pp. 591–600.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献